计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R647061-5mg |
5mg |
期货 ![]() |
| |
| R647061-10mg |
10mg |
期货 ![]() |
| |
| R647061-50mg |
50mg |
期货 ![]() |
| |
| R647061-100mg |
100mg |
期货 ![]() |
|
| 别名 | 磷酸瑞格列汀 |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | Retagliptin phosphate |
| 生化机理 | 磷酸瑞格列汀(SP2086 phosphate)是一种选择性、竞争性和口服活性二肽基肽酶-4(DPP-4)抑制剂。磷酸瑞格列汀可用于 2 型糖尿病(T2DM)研究。 |
| 储存温度 | 2-8°C储存,干燥 |
| 运输条件 | 冰袋运输 |
| 产品介绍 |
Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research In Vitro Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:DPP-4 |
| 纯度 | ≥99% |
| Smiles | COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O |
|---|---|
| Isomeric SMILES | COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O |
| PubChem CID | 49820554 |
| 分子量 | 562.36 |
| 溶解性 | DMSO : ≥ 150 mg/mL (266.73 mM) |
|---|---|
| 分子量 | 562.400 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 15 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 562.105 Da |
| 单同位素质量Monoisotopic Mass | 562.105 Da |
| 拓扑极表面积Topological Polar Surface Area | 168.000 Ų |
| 重原子数Heavy Atom Count | 37 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 748.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |